PARP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.992400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.149800E-01
Normal-vs-Stage2
4.939800E-01
Normal-vs-Stage3
1.543380E-01
Normal-vs-Stage4
3.625800E-01
Stage1-vs-Stage2
6.196600E-01
Stage1-vs-Stage3
4.650800E-01
Stage1-vs-Stage4
9.497000E-01
Stage2-vs-Stage3
2.108600E-01
Stage2-vs-Stage4
6.314000E-01
Stage3-vs-Stage4
5.720000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.510000E-01
Normal-vs-AfricanAmerican
8.721800E-02
Normal-vs-Asian
2.146400E-01
Caucasian-vs-AfricanAmerican
1.963160E-01
Caucasian-vs-Asian
3.629600E-01
AfricanAmerican-vs-Asian
4.964600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.872600E-01
Normal-vs-Female
5.300400E-01
Male-vs-Female
8.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.846000E-01
Normal-vs-Age(41-60Yrs)
6.304400E-01
Normal-vs-Age(61-80Yrs)
4.402000E-01
Normal-vs-Age(81-100Yrs)
6.963000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.234800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.693200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.352400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.877810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.701800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.290360E-01
Normal-vs-Daily Drinker
6.315200E-01
Normal-vs-Weekly Drinker
6.388200E-01
Normal-vs-Occasional Drinker
6.645000E-01
Normal-vs-Social Drinker
6.121200E-01
Non Drinker-vs-Daily Drinker
2.680600E-01
Non Drinker-vs-Weekly Drinker
3.452800E-01
Non Drinker-vs-Occasional Drinker
6.382200E-02
Non Drinker-vs-Social Drinker
7.652000E-02
Daily Drinker-vs-Weekly Drinker
9.872600E-01
Daily Drinker-vs-Occasional Drinker
7.309000E-01
Daily Drinker-vs-Social Drinker
7.766600E-01
Weekly Drinker-vs-Occasional Drinker
7.613200E-01
Weekly Drinker-vs-Social Drinker
8.000600E-01
Occasional Drinker-vs-Social Drinker
9.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.951000E-01
Normal-vs-Grade 2
9.658800E-01
Normal-vs-Grade 3
9.617000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.557200E-01
Grade 1-vs-Grade 3
5.411800E-01
Grade 1-vs-Grade 4
9.951000E-01
Grade 2-vs-Grade 3
6.279500E-02
Grade 2-vs-Grade 4
9.658800E-01
Grade 3-vs-Grade 4
9.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.928170E-01
Normal-vs-NonDiabetic
5.700200E-01
Diabetic-vs-NonDiabetic
9.659600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.779610E-01
Normal-vs-NoPancreatitis
4.161800E-01
Pancreatitis-vs-NoPancreatitis
5.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.619800E-01
Normal-vs-N1
5.228800E-01
N0-vs-N1
9.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.942000E-01
Normal-vs-TP53-NonMutant
6.540200E-01
TP53-Mutant-vs-TP53-NonMutant
1.174390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
